metoclopramide has been researched along with HIV Coinfection in 9 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although past attempts to reverse anorexia-cachexia have generally been disappointing, several promising new pharmacologic approaches are currently being evaluated, including megestrol acetate, hydrazine sulfate, metoclopramide, and dronabinol." | 4.78 | Management of anorexia-cachexia associated with cancer and HIV infection. ( Gorter, R, 1991) |
| " Using a Delphi study method, physicians were asked to rank preferences of drug and dosing schedule for first-line opioid, antiemetic, and laxative for the treatment of adults with chronic pain due to cancer and other life-threatening conditions." | 1.38 | Strategic pain management: the identification and development of the IAHPC opioid essential prescription package. ( Bennett, MI; Bruera, E; De Lima, L; Nekolaichuk, C; Ripamonti, CI; Vignaroli, E; Wenk, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogunlesi, TA | 1 |
| Adekanmbi, FA | 1 |
| Fetuga, BM | 1 |
| Ogundeyi, MM | 1 |
| Vignaroli, E | 1 |
| Bennett, MI | 1 |
| Nekolaichuk, C | 1 |
| De Lima, L | 1 |
| Wenk, R | 1 |
| Ripamonti, CI | 1 |
| Bruera, E | 1 |
| Leaños-Miranda, A | 1 |
| Contreras-Hernández, I | 1 |
| Parra, A | 3 |
| Ramírez-Peredo, J | 3 |
| Coutiño, B | 2 |
| Lagunes, B | 1 |
| Marín, A | 1 |
| Ponce de Leon, S | 1 |
| Ruiz-Argüelles, GJ | 1 |
| Oudesluys-Murphy, AM | 1 |
| Snowden, H | 1 |
| Woolridge, M | 1 |
| Renfrew, M | 1 |
| Larrea, F | 2 |
| Pérez-Romano, B | 2 |
| Cabrera, V | 2 |
| Torres, I | 2 |
| Reyes-Núñez, V | 1 |
| Ruiz-Argüelles, G | 2 |
| Ruiz-Argüelles, A | 2 |
| Angeles, A | 1 |
| Gorter, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Critical Illness Stress-induced Immune Suppression Prevention Trial[NCT00395161] | Phase 3 | 293 participants (Actual) | Interventional | 2007-04-30 | Terminated (stopped due to Terminated for futility on 11/30/09 based on the recommendation of the DSMB) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00395161)
Timeframe: 28 days after admission to the PICU
| Intervention | participants (Number) |
|---|---|
| Enteral Zinc, Selenium, Glutamine, and IV Metoclopramide | 15 |
| Enteral Whey Protein, IV Saline | 8 |
(NCT00395161)
Timeframe: 48 hours after admission until PICU discharge
| Intervention | Days (Median) |
|---|---|
| Enteral Zinc, Selenium, Glutamine, and IV Metoclopramide | 1 |
| Enteral Whey Protein, IV Saline | 2 |
What is reported is the number of participants with counts qualifying as lymphopenia. (NCT00395161)
Timeframe: from time of PICU admission till discharge from PICU
| Intervention | participants (Number) |
|---|---|
| Enteral Zinc, Selenium, Glutamine, and IV Metoclopramide | 5 |
| Enteral Whey Protein, IV Saline | 12 |
(NCT00395161)
Timeframe: 48 hours after PICU admission till discharge from PICU
| Intervention | Mean number of events per 100 study days (Mean) |
|---|---|
| Daily Nutriceutical Supplementation | 4.99 |
| Whey Protein | 4.83 |
(NCT00395161)
Timeframe: 48 hours after admission until 5 days after discharged from the PICU
| Intervention | Days (Median) |
|---|---|
| Daily Nutriceutical Supplementation | 12.1 |
| Whey Protein | 13.2 |
2 reviews available for metoclopramide and HIV Coinfection
| Article | Year |
|---|---|
Non-puerperal induced lactation: an infant feeding option in paediatric HIV/AIDS in tropical Africa.
Topics: Africa; Attitude to Health; Breast Feeding; Chlorpromazine; Communication; Family; Female; Health Ed | 2008 |
Management of anorexia-cachexia associated with cancer and HIV infection.
Topics: Anorexia; Antineoplastic Agents; Cachexia; Dronabinol; HIV Infections; Humans; Hydrazines; Megestrol | 1991 |
7 other studies available for metoclopramide and HIV Coinfection
| Article | Year |
|---|---|
Strategic pain management: the identification and development of the IAHPC opioid essential prescription package.
Topics: Analgesics, Opioid; Antiemetics; Clinical Protocols; Constipation; Delphi Technique; Dioctyl Sulfosu | 2012 |
Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus.
Topics: Adult; Aged; Autoantibodies; HIV Infections; Humans; Hyperprolactinemia; Male; Metoclopramide; Middl | 2002 |
Impaired metoclopramide-induced pituitary prolactin release in men with human immunodeficiency virus infection.
Topics: Adult; Area Under Curve; CD4 Lymphocyte Count; Dopamine Antagonists; HIV Infections; HIV Seronegativ | 1999 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Galactorrhea; HIV Infections; HIV Protease Inhibitors; Humans; La | 2001 |
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
Topics: Drug Therapy, Combination; Female; Fluoxetine; Galactorrhea; HIV Infections; HIV Protease Inhibitors | 2001 |
Serum prolactin is associated with apoptosis in men with human immunodeficiency virus infection.
Topics: Adult; Animals; Apoptosis; Area Under Curve; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell | 2001 |
Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection.
Topics: Adult; Area Under Curve; Case-Control Studies; CD4 Lymphocyte Count; Cross-Sectional Studies; Dopami | 2001 |